Biomm SA Valuation
| BIOM3 Stock | BRL 7.88 0.23 2.84% |
At this time, the firm appears to be undervalued. Biomm SA shows a prevailing Real Value of R$8.57 per share. The current price of the firm is R$7.88. Our model approximates the value of Biomm SA from analyzing the firm fundamentals such as Profit Margin of (0.99) %, return on equity of -0.77, and Current Valuation of 554.55 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Biomm SA's price fluctuation is somewhat reliable at this time. Calculation of the real value of Biomm SA is based on 3 months time horizon. Increasing Biomm SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biomm stock is determined by what a typical buyer is willing to pay for full or partial control of Biomm SA. Since Biomm SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomm Stock. However, Biomm SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.88 | Real 8.57 | Hype 7.88 | Naive 6.94 |
The intrinsic value of Biomm SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biomm SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biomm SA helps investors to forecast how Biomm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomm SA more accurately as focusing exclusively on Biomm SA's fundamentals will not take into account other important factors: Biomm SA Total Value Analysis
Biomm SA is currently projected to have takeover price of 554.55 M with market capitalization of 434.89 M, debt of 134.07 M, and cash on hands of 30.58 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biomm SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
554.55 M | 434.89 M | 134.07 M | 30.58 M |
Biomm SA Investor Information
About 52.0% of the company shares are held by company insiders. The book value of Biomm SA was currently reported as 1.65. The company recorded a loss per share of 1.19. Biomm SA had not issued any dividends in recent years. The entity had 3:1 split on the 21st of March 2013. Based on the key measurements obtained from Biomm SA's financial statements, Biomm SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Biomm SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biomm SA has an asset utilization ratio of 28.96 percent. This implies that the Company is making R$0.29 for each dollar of assets. An increasing asset utilization means that Biomm SA is more efficient with each dollar of assets it utilizes for everyday operations.Biomm SA Ownership Allocation
Biomm SA holds a total of 81.29 Million outstanding shares. Biomm SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biomm SA Profitability Analysis
The company reported the revenue of 107.09 M. Net Loss for the year was (80.26 M) with profit before overhead, payroll, taxes, and interest of 26.93 M.About Biomm SA Valuation
The stock valuation mechanism determines Biomm SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Biomm SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biomm SA. We calculate exposure to Biomm SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomm SA's related companies.It offers AFREZZA, a human insulin inhalation powder CONFORT CARE, a moisturizing foot cream GLARGILIN, a glargine insulin and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in So Paulo, Brazil. BIOMM ON operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 94 people.
8 Steps to conduct Biomm SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biomm SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biomm SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biomm SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biomm SA's revenue streams: Identify Biomm SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biomm SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biomm SA's growth potential: Evaluate Biomm SA's management, business model, and growth potential.
- Determine Biomm SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biomm SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Biomm Stock Analysis
When running Biomm SA's price analysis, check to measure Biomm SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomm SA is operating at the current time. Most of Biomm SA's value examination focuses on studying past and present price action to predict the probability of Biomm SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomm SA's price. Additionally, you may evaluate how the addition of Biomm SA to your portfolios can decrease your overall portfolio volatility.